TOKYO, April 14, 2026 /PRNewswire/ -- Kato Pleasure Group proudly announces that FUFU Tokyo Ginza, the flagship urban property of FUFU JAPAN's small luxury resorts, has been named to TIME's World's Greatest Places of 2026, an annual list highlighting 100 extraordinary destinations around the globe that deliver transformative travel experiences.
Each year, TIME compiles the list through nominations from its global network of correspondents and contributors, spotlighting destinations that offer distinctive travel experiences. FUFU Tokyo Ginza was recognized for its masterful fusion of traditional Japanese ryokan serenity and the dynamic energy of metropolitan Tokyo – creating a rare urban sanctuary in the heart of Tokyo.
Read the TIME feature here: Fufu Tokyo Ginza
See the full list here: The World's Greatest Places of 2026.
Opened in November 2025, FUFU Tokyo Ginza represents the brand's first property in a major metropolitan setting. Situated in the Ginza 1-chome district, Tokyo's historic hub of luxury and sophistication, the property reimagines urban hospitality by blending the timeless tranquility of a traditional ryokan with the pulse of modern city life.
At the core of FUFU Tokyo Ginza is the brand's guiding philosophy: 'A Place to Savor Time.' Amid Ginza's bustling streets, the hotel offers an intimate retreat designed to slow the pace of life. With only 34 guest rooms, each featuring a private garden and natural hot spring bath, guests enjoy a deeply personal experience rarely found in a global metropolis.
Every room includes a private onsen filled with mineral-rich hot spring water drawn directly from the original source at FUFU Atami, where the brand was founded. This signature experience brings Japan's revered onsen culture into the heart of the city, enabling guests to enjoy an authentic wellness ritual without leaving urban landscape.
The property engages all five senses through refined design and amenities. The Rooftop Lounge Yusora offers a tranquil escape above the skyline, complete with open-air footbaths surrounded by greenery, curated beverages, and sweeping views of Ginza. Complementing this are two exceptional dining venues:
Thoughtful design incorporates natural materials, soft textures, and subtle lighting to evoke warmth and calm, an intentional contrast to Tokyo's typical steel-and-glass architecture. This approach fosters privacy and seclusion high above the city streets.
FUFU Tokyo Ginza is part of FUFU JAPAN brand, a portfolio of small luxury resorts in culturally and scenically rich destinations, including Hakone, Kyoto, Nara, and Kawaguchiko. Since its founding in 2007, the brand has been celebrated for harmonizing traditional Japanese sensibilities with contemporary luxury. Notably, seven FUFU properties have received Michelin Key distinctions for two consecutive years (2024 and 2025), more than any other Japanese hotel brands.
The inclusion of FUFU Tokyo Ginza in TIME's World's Greatest Places of 2026 underscores the brand's continued evolution and its ability to present authentic Japanese hospitality for a global audience. As international travelers seek meaningful, culturally grounded experiences, FUFU Tokyo Ginza stands out as a destination offering both immersion and escape in the center of one of the world's most dynamic cities.
Property Overview
Name: FUFU TOKYO GINZA
Address: Hulic Ginza Building, 1-7-10 Ginza, Chuo-ku, Tokyo
*Directly connected to Ginza-itchome Station (Exit 6) on the Tokyo Metro Yurakucho Line
Guest rooms: 34 rooms (11 types)
Rates: Quote per room for 2 persons (tax and service charge included; bathing tax and accommodation tax excluded)
From ¥115,000 / $747 (room only)
From ¥125,000 / $811 (with breakfast)
From ¥161,000 / $1045 (with dinner and breakfast)
*Note: USD amounts are approximate and subject to change depending on the exchange rate.
IN/OUT: 15:00 / 11:00
Official website: https://www.fufutokyo.jp/en/
Official Instagram: https://www.instagram.com/fufu_tokyo_ginza/
About FUFU JAPAN
Guided by the concept of "A Place to Savor Time," FUFU JAPAN is a small luxury resort brand with ten properties across Japan. Each FUFU resort offers natural hot-spring baths in every guest room, regionally inspired cuisine, and deeply personalized hospitality. Designed to provide privacy, comfort, and authentic cultural experiences, FUFU invites guests to experience Japan at a slower, more meaningful pace.
FUFU JAPAN Official Website: https://www.fufujapan.jp/en/
FUFU JAPAN Official Instagram: https://www.instagram.com/fufu_japan_official/
Photo - https://mma.prnewswire.com/media/2955636/Left_FUFU_Tokyo_Ginza_guest_room__Executive_Luxury_Corner_Suite.jpg
Photo - https://mma.prnewswire.com/media/2955637/c__Photograph_Matt_Dutile.jpg
Photo - https://mma.prnewswire.com/media/2955638/Left_Rooftop_Lounge_Yusora_Right_SUSHI_GINGA.jpg
Logo - https://mma.prnewswire.com/media/2955711/FUFU_TOKYO_GINZA_logo_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/urban-onsen-sanctuary-fufu-tokyo-ginza-named-to-times-worlds-greatest-places-of-2026-302741538.html
Die österreichische Marinomed Biotech AG hat ihre angekündigte Barkapitalerhöhung erfolgreich abgeschlossen und damit ihre kurzfristige Finanzierung gesichert. Insgesamt platzierte das in Korneuburg ansässige Unternehmen 159.039 neue Aktien und erzielte einen Bruttoemissionserlös von rund 2,23 Millionen Euro. Das ursprünglich kommunizierte Ziel von mindestens 2 Millionen Euro wurde damit übertroffen.
Von den neuen Papieren wurden 33.322 Aktien im Rahmen eines Bezugsangebots von bestehenden Aktionären über Bezugsrechte gezeichnet. Die nicht bezogenen Aktien platzierte Marinomed anschließend in einer prospektfreien Privatplatzierung bei Investoren zu einem Bezugspreis von 14 Euro je Aktie. Auf diesem Weg konnten weitere 125.717 Aktien am Markt untergebracht werden.
CEO Andreas Grassauer wertete den Platzierungserfolg als Vertrauensbeweis der Investoren. Die Kapitalmaßnahme sichere die finanzielle Grundlage, um die geplanten Meilensteine zu erreichen, und decke den erwarteten Liquiditätsbedarf, sagte er laut Unternehmensmitteilung. Zugleich stärke die zusätzliche Eigenkapitalbasis die Position des Biotech-Unternehmens in den laufenden Verhandlungen zur Vermarktung der Leitprodukte Budesolv und Tacrosolv.
Die neuen Aktien werden unter der bestehenden ISIN ATMARINOMED6 an der Wiener Börse gehandelt. Am Sekundärmarkt reagierte die Aktie positiv auf die Nachrichtenlage: Zum Zeitpunkt der Meldung wurde das Papier auf der Handelsplattform Lang & Schwarz mit einem Plus von 4,62 % bei 13,60 Euro taxiert.
